Covered recipient · General Payments record
SAMANEH YOUSEFI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$4,424.66
- Reported across 122 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,735.62 | 52 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $359.64 | 19 |
| UCB, Inc. | $292.08 | 11 |
| Neurocrine BioSciences, Inc. | $282.54 | 3 |
| JAZZ PHARMACEUTICALS INC. | $184.09 | 3 |
| Alexion Pharmaceuticals, Inc. | $130.08 | 1 |
| Ultragenyx Pharmaceutical Inc. | $105.63 | 1 |
| CSL Behring | $92.00 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $63.63 | 2 |
| ARGENX US, INC. | $63.52 | 2 |
| Lilly USA, LLC | $61.71 | 2 |
| SCILEX PHARMACEUTICALS INC. | $37.24 | 2 |
| SK Life Science, Inc. | $34.91 | 1 |
| Alnylam Pharmaceuticals Inc. | $28.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (52)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.77 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454458 | CMS |
| ABBVIE INC. | $25.69 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454460 | CMS |
| ABBVIE INC. | $6.30 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454462 | CMS |
| ABBVIE INC. | $33.45 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454464 | CMS |
| ABBVIE INC. | $124.88 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454466 | CMS |
| ABBVIE INC. | $6.96 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454468 | CMS |
| ABBVIE INC. | $12.67 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454470 | CMS |
| ABBVIE INC. | $5.25 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454472 | CMS |
| ABBVIE INC. | $9.89 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454474 | CMS |
| ABBVIE INC. | $3.44 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454476 | CMS |
| ABBVIE INC. | $7.48 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454478 | CMS |
| ABBVIE INC. | $5.58 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454480 | CMS |
| ABBVIE INC. | $4.80 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454482 | CMS |
| ABBVIE INC. | $5.65 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454484 | CMS |
| ABBVIE INC. | $6.06 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454486 | CMS |
| ABBVIE INC. | $8.31 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454488 | CMS |
| ABBVIE INC. | $7.89 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454490 | CMS |
| ABBVIE INC. | $32.08 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454492 | CMS |
| ABBVIE INC. | $23.49 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108454494 | CMS |
| Alexion Pharmaceuticals, Inc. | $130.08 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094022540 | CMS |
| Alnylam Pharmaceuticals Inc. | $28.55 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125839115 | CMS |
| ARGENX US, INC. | $33.79 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142143269 | CMS |
| ARGENX US, INC. | $29.73 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142145779 | CMS |
| CSL Behring | $14.70 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134600835 | CMS |
| CSL Behring | $21.93 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134600839 | CMS |
| CSL Behring | $27.84 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134600859 | CMS |
| CSL Behring | $27.53 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134600863 | CMS |
| JAZZ PHARMACEUTICALS INC. | $149.99 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151301604 | CMS |
| JAZZ PHARMACEUTICALS INC. | $14.82 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151301602 | CMS |
| JAZZ PHARMACEUTICALS INC. | $19.28 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151301600 | CMS |
| Lilly USA, LLC | $26.73 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135926864 | CMS |
| Lilly USA, LLC | $34.98 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135940768 | CMS |
| Neurocrine Biosciences, Inc. | $133.22 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150919370 | CMS |
| Neurocrine Biosciences, Inc. | $140.00 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150918248 | CMS |
| Neurocrine Biosciences, Inc. | $9.32 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151015689 | CMS |
| SCILEX PHARMACEUTICALS INC. | $23.57 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136276375 | CMS |
| SCILEX PHARMACEUTICALS INC. | $13.67 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136284435 | CMS |
| SK Life Science, Inc. | $34.91 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154152519 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.91 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137848262 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.72 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137848264 | CMS |
| UCB, Inc. | $39.17 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143298942 | CMS |
| UCB, Inc. | $28.78 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143298946 | CMS |
| UCB, Inc. | $5.37 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143298951 | CMS |
| UCB, Inc. | $38.59 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143298955 | CMS |
| UCB, Inc. | $39.06 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143298960 | CMS |
| UCB, Inc. | $26.04 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143298964 | CMS |
| UCB, Inc. | $8.23 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143298968 | CMS |
| UCB, Inc. | $41.56 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143298973 | CMS |
| UCB, Inc. | $37.05 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143298977 | CMS |
| UCB, Inc. | $2.52 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143298981 | CMS |
| UCB, Inc. | $25.71 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143298986 | CMS |
| Ultragenyx Pharmaceutical Inc. | $105.63 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153281767 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.